8-bromo-6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
≥95%
- Product Code: 194264
CAS:
1428532-90-4
Molecular Weight: | 228.05 g./mol | Molecular Formula: | C₇H₆BrN₃O |
---|---|---|---|
EC Number: | MDL Number: | MFCD23701112 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of potent kinase inhibitors, particularly targeting protein kinases involved in inflammatory diseases and cancer. Its structure allows for selective binding and modulation of enzyme activity, making it valuable in developing small-molecule therapeutics. Also explored in the design of CNS-active compounds due to its ability to cross the blood-brain barrier and interact with neurological targets.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | €196.39 |
+
-
|
0.250 | 10-20 days | €350.12 |
+
-
|
1.000 | 10-20 days | €991.51 |
+
-
|
8-bromo-6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one
Used in pharmaceutical research as a key intermediate in the synthesis of potent kinase inhibitors, particularly targeting protein kinases involved in inflammatory diseases and cancer. Its structure allows for selective binding and modulation of enzyme activity, making it valuable in developing small-molecule therapeutics. Also explored in the design of CNS-active compounds due to its ability to cross the blood-brain barrier and interact with neurological targets.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :